Improving the quality of stroke/ TIA care will not lower prevalence, however, it may reduce the risk of complications/ future events; improve quality of life for the patient and their carers/ families; reduce inequity in health outcomes; or reduce (or increase) health and social care utilisation and costs.
The Stroke delivery plan (WG 2017) recommends that personalised secondary prevention is discussed with stroke survivors at regular reviews, including six month reviews.
For signposting to relevant NICE guidelines/ quality standards relating to secondary prevention of stroke/ TIA as a source of potential improvement actions, see below